Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation

Gemcitabine (GEM) resistance remains a challenging clinical issue to overcome in chemotherapy against pancreatic cancer. We previously demonstrated that miR-210 derived from pancreatic cancer stem cells enhanced the GEM-resistant properties of pancreatic cancer cells, thus identifying miR-210 as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fei, Wu, Heshui, Xiong, Jiongxin, Peng, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100451/
https://www.ncbi.nlm.nih.gov/pubmed/33968986
http://dx.doi.org/10.3389/fmolb.2021.645365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100451/
https://www.ncbi.nlm.nih.gov/pubmed/33968986
http://dx.doi.org/10.3389/fmolb.2021.645365

Ejemplares similares